Arcview Capital
Arcview Capital is a FINRA-registered broker-dealer providing private placements, equity crowdfunding, private funds, and Reg A+ offerings to cannabis, hemp, psychedelics, and plant-medicine issuers, serving both accredited and non-accredited investors.
- Company typePrivate
- Founded2020
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingServices
What Arcview Capital does
Arcview Capital is a FINRA-registered broker-dealer (LLC, founded 2020) headquartered in Brooklyn, New York, operating as the capital-markets arm of The Arcview Group ecosystem. The firm serves cannabis, hemp, psychedelics, and plant-medicine companies seeking to raise capital, and accredited and non-accredited investors seeking exposure to these sectors. Its core products are private placements (select-investor debt or equity raises), private funds (alternative investment vehicles), Reg A+ offerings (up to $75M capacity), and a Reg CF equity crowdfunding platform launched in May 2022.
The platform architecture combines a self-serve issuer application and campaign analytics dashboard with an investor portal that supports credit card, ACH, and bank wire payments, and is integrated with KoreConX's All-In-One blockchain-based infrastructure for stakeholder communications. Issuers (e.g., Budbo at $493.95 minimum, MJ REIT at $25,000 minimum for accredited investors, and Ei. Ventures in Reg A+ at $498.94 minimum) access dedicated account management, SEC filing assistance, and marketing support.
The revenue model is transaction-fee based: a 7% success fee on crowdfunding raises charged to issuers, plus a percentage of private placement sales concessions (with an additional 2% equity stake required by a platform partner). Arcview Capital does not charge fees directly to investors. The firm markets through The Arcview Group's events, advocacy programs, and newsroom, with named social-justice nonprofit partners including The Hood Incubator, Last Prisoner Project, NDICA, and Minorities for Medical Marijuana.
Arcview Capital firmographics
Firmographics- Name
- Arcview Capital
- Legal name
- Arcview Capital, LLC
- Website
- https://arcviewcapital.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Arcview Capital is a FINRA-registered broker-dealer providing private placements, equity crowdfunding, private funds, and Reg A+ offerings to cannabis, hemp, psychedelics, and plant-medicine issuers, serving both accredited and non-accredited investors.
- Ownership category
- akta.pro rank
Arcview Capital industry classification
Industry- Product category
- Broker-Dealer Services
- NAICS
- Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523), Portfolio Management and Investment Advice (523940)
- SIC
- Security Brokers, Dealers & Flotation Companies (6211), Investment Advice (6282)
- akta.pro primary industry
- Capital Raising Advisory (Equity & Equity-Linked) (FSAEAGAC)
- akta.pro secondary industries
- Capital Raising Advisory (Debt/Equity/Private Capital) (BPAHADAG), Real Estate Capital Markets Advisory (Debt/Equity Placement, Refinancing) (BPAJANAE)
Keywords
Where Arcview Capital is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Arcview Capital business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Crowdfunding Platform Fees: Arcview Capital charges issuers a 7% success fee on the total amount raised during crowdfunding campaigns. The fee is only imposed on actual funds raised, not on the funding goal.
- Private Placement Sales Concessions: The firm receives a percentage of the amount of money raised by issuers of private placement interests. Financial professionals are compensated through a combination of salary, annual bonus, and/or a percentage of the sales concession Arcview receives from completed transactions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Crowdfunding Success Fee - 7% of funds raised |
| Other | Pay-as-you-go | Investment minimums vary by offering |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Arcview Capital product offering
Product offeringCore offering
Arcview Capital is a FINRA-registered broker-dealer that helps cannabis, hemp, and psychedelic companies raise capital through private placements, private funds, and equity crowdfunding (Reg CF, Reg A+). It connects issuers with a network of accredited and non-accredited investors while providing dedicated account management, SEC filing assistance, and marketing support throughout the capital-raising process.
Product overview
Arcview Capital is a broker-dealer platform offering three core investment products: Equity Crowdfunding (Reg CF), Private Placements, and Private Funds. The platform serves both issuers seeking capital in the cannabis and plant-based industries, and investors looking to access these alternative investments. The ecosystem includes issuer onboarding with dedicated account managers, marketing support, SEC filing assistance, and real-time campaign analytics. The company also facilitates investment in specific portfolio companies including Budbo (cannabis technology), Ei. Ventures (psychedelics), and MJ REIT (cannabis real estate).
Differentiator
Problem solved
Functional benefit
Products and services
- Equity Crowdfunding Platform A full-service equity crowdfunding platform that enables cannabis and plant-based businesses to raise capital from both accredited and non-accredited investors through SEC Regulation CF offerings. Target issuers are cannabis companies seeking growth capital without traditional financing access.
- Private Placements Private placement brokerage services providing a private alternative to publicly offered securities for raising capital, available to select investors, used by both public and private companies seeking long-term fixed-rate capital.
- Private Funds Investment vehicles in the form of debt or equity that focus on private, non-public companies, offering alternative investment approaches including long/short hedge fund strategies.
- Regulation A+ Offerings Reg A+ filings enabling companies to raise up to $75 million every 12 months, with offerings for psychedelics and plant medicines such as Ei. Ventures.
Quantifiable outcome
- First broker-dealer to offer a cannabis-focused equity crowdfunding platform
- +1 more outcomes
Companies that use Arcview Capital
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Arcview Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Arcview Capital partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- KoreConXcoreKoreConX, a secure All-In-One platform for private companies' capital market activity, partnered with Arcview Capital to provide technology infrastructure for cannabis industry investing. The partnership enables companies raising capital and investors to access technology, market leadership, and security through the KoreConX ecosystem.
- The Arcview GroupcoreArcview Capital is an integral part of The Arcview Group ecosystem, which includes Arcview Consulting, Arcview Ventures, and Arcview Alliances/Partners. The Arcview Group has been a trusted global leader for over 12 years servicing the cannabis, hemp, and psychedelic industries.
- The Hood IncubatorminorNonprofit partner committed to ending the drug war and reversing its harmful impacts on Black communities. Arcview supports through social justice initiatives and donations.
- Last Prisoner ProjectminorNonprofit focused on criminal justice reform initiatives including prisoner release, record clearing through clemency & expungement, and reentry programs. Arcview supports through social justice initiatives and donations.
- NDICA (National Diversity and Inclusion Cannabis Alliance)minorFounded to create social equity, social justice and diversity for those affected by the War on Drugs. Arcview supports through social justice initiatives and donations.
- Minorities for Medical MarijuanaminorCommitted to cultivating a culturally inclusive environment where diversity of thought, experience and opportunities are valued, respected, appreciated and celebrated. Arcview supports through social justice initiatives and donations.
Scale indicators6 records
Recent moves4 records
Expansion highlights5 records
Arcview Capital competitors and assessment
Company assessmentBroad incumbents
- SeedInvest: An established equity crowdfunding platform supporting Reg CF, Reg A+, and other private offerings. Comparable in product type (online private placement and Reg CF platform), but generalist rather than cannabis-focused.
- StartEngine: A large generalist equity crowdfunding platform with both Reg CF and Reg A+ offerings. Comparable in product mechanics to Arcview's crowdfunding platform but is a broad incumbent rather than a cannabis specialist.
- Wefunder: A leading U.S. equity crowdfunding platform running Reg CF and Reg A+ offerings. Comparable on the crowdfunding side of Arcview's business but is a generalist with much broader deal flow and not cannabis-specialized.
- Republic: One of the largest generalist equity crowdfunding platforms in the U.S. Comparable as a competing Reg CF/Reg A+ platform that is moving into cannabis and psychedelics offerings, though it operates across all industries rather than as a cannabis specialist.
Direct peers
- GreenWave Advisors: A cannabis-focused financial advisory and capital markets firm. Comparable as a specialist capital-formation and advisory competitor serving cannabis issuers in the same regulatory and investor landscape.
- Viridian Capital Advisors: A cannabis-focused financial advisory and investment bank that raises capital for cannabis companies via private placements, debt, and equity. Directly comparable to Arcview Capital's broker-dealer and capital-raise function in the same vertical.
- Cova Ventures: A cannabis-focused investment platform that connects investors with cannabis deals. Comparable as a cannabis-specialist capital-formation platform competing for the same issuer and investor base as Arcview.
Emerging players
- MainStem: A cannabis capital and investment platform. Comparable as a cannabis-specific capital-formation player, though with a narrower offering set than Arcview's FINRA-regulated broker-dealer suite.
- Fundanna: A cannabis-specialist equity crowdfunding platform. Compares as a more narrowly cannabis-focused crowdfunding competitor lacking Arcview's FINRA broker-dealer license.
Others
- KoreConX: An all-in-one technology platform for private company capital markets, currently a technology partner of Arcview Capital. Comparable as an enabling/ecosystem participant rather than a direct competitor—it provides cap table, stakeholder, and compliance infrastructure that adjacent broker-dealers also use.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Arcview Capital social profiles
Digital presenceArcview Capital compliance and trust
Trust signalCompliance2 records
Arcview Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Arcview Capital leadership team
Management profileNumber of profiles
Profiles2 records
Arcview Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Arcview Capital M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Arcview Capital
What does Arcview Capital do?
Arcview Capital is a FINRA-registered broker-dealer that helps cannabis, hemp, and psychedelic companies raise capital through private placements, private funds, and equity crowdfunding (Reg CF, Reg A+). It connects issuers with a network of accredited and non-accredited investors while providing dedicated account management, SEC filing assistance, and marketing support throughout the capital-raising process.
Is Arcview Capital a public or private company?
Arcview Capital is a private company. It is classified as corporate owned and is currently operating.
When was Arcview Capital founded?
Arcview Capital was founded in 2020. It employs 1 to 10 people.
Where is Arcview Capital based?
Arcview Capital is headquartered in New York, United States, in the North America region.
How does Arcview Capital make money?
Two revenue lines are on record. Crowdfunding Platform Fees are the primary driver. The others are private Placement Sales Concessions.
Who are Arcview Capital's main competitors?
Broad incumbents on record are SeedInvest, StartEngine, Wefunder and Republic. Direct peers are GreenWave Advisors, Viridian Capital Advisors and Cova Ventures. Emerging players are MainStem and Fundanna. KoreConX is listed as an others.
Does Arcview Capital have an API?
No public API is recorded for Arcview Capital.
What industry is Arcview Capital in?
Arcview Capital's product category is Broker-Dealer Services. Its primary akta.pro industry code is FSAEAGAC, Capital Raising Advisory (Equity & Equity-Linked), with a secondary code of BPAHADAG, Capital Raising Advisory (Debt/Equity/Private Capital). Its NAICS code is 523 and its SIC code is 6211.